Yes, “KPop Demon Hunters” makes the list. But that was just one of the standouts in a great year. By Maya Phillips My list of favorite animation this year includes time-traveling rainbow people, ...
Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program. The alliance ...
Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical utility study demonstrating that the PromarkerD blood test provides actionable ...
Animation has always enjoyed a devoted following, but 2025’s releases revealed that its audience is bigger and broader than most of us thought. In a tough year for most live-action releases, one of ...
Atrasentan received FDA approval for IgA nephropathy, reducing proteinuria by 36% and showing consistent efficacy across diverse patient groups. Value-based care programs significantly slowed CKD ...
EXCLUSIVE: L.A. publisher Gungnir is launching an animation studio that will feed an in-house YouTube channel that planned as “the Cartoon Network of the digital era.” Gungnir Animation Studio will ...
The Golden Globes announced this year’s nominations this morning, and the animation categories are already sparking conversation. The Globes’ animated feature winner often goes on to repeat at the ...
CKD prevalence has more than doubled since 1990, with 788 million adults affected in 2023, highlighting a significant global health challenge. The disease is a major contributor to cardiovascular ...
Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past? A healthy ...
HOUSTON — The benefits of SGLT2 inhibitors in slowing kidney disease progression are similar regardless of patients’ type 2 diabetes (T2D) or albuminuria status, the results of a recent meta-analysis ...
The number of adults living with chronic kidney disease (CKD) has more than doubled since 1990, reaching nearly 800 million worldwide, according to new research published in The Lancet. The findings ...